Abstract
Purpose
Studies have suggested that appraisal of relapse risk and knowledge of medications in relapse prevention may shape one’s reactions towards an illness and treatment, and influence the illness outcome. The aim of this study is to explore patients’ and caregivers’ knowledge of medications, perceived chances of relapse and its predictors, as well as their relations with medication adherence.
Methods
Eighty patient–caregiver dyads participated in the study. Their knowledge about psychosis, specific knowledge about medications and course of illness of their own and their relatives, medication adherence and symptomatology of patients were assessed. Differences in knowledge between patients and caregivers were compared. The link between adherence with perceived relapse risk and consequences of stopping medication were explored. Multinomial regression analyses were performed to examine predictors of perceived relapse risk.
Results
More patients underestimated their chance of relapse and were unaware that stopping medication may lead to relapse. The lack of understanding about the effect of stopping medication of both caregivers and patients was related to poor medication adherence of patients. Patients perceived of having higher chance of relapse had more severe positive symptoms. Positive symptoms of patients and greater knowledge about psychosis of caregivers were related to higher caregivers’ perceived relapse risk of their relative.
Conclusions
This study explored the views of patients and their caregivers on the perceived risk of relapse and role of medication in preventing relapse, and the potential significance. Specific interventions addressing these areas should be considered in developing relapse prevention programs.
Similar content being viewed by others
References
Adams J, Scott J (2000) Predicting medication adherence in severe mental disorders. Acta Psychiatr Scand 101(2):119–124
Almond S, Knapp M, Francois C, Toumi M, Brugha T (2004) Relapse in schizophrenia: costs, clinical outcomes and quality of life. Br J Psychiatry 184:346–351
Alvarez-Jimenez M, Priede A, Hetrick SE et al (2012) Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies. Schizophr Res 139(1–3):116–128
Barrowclough C, Tarrier N, Watts S, Vaughn C, Bamrah J, Freeman H (1987) Assessing the functional value of relatives’ knowledge about schizophrenia: a preliminary report. Br J Psychiatry 151(1):1–8
Bentley K, Walsh J (2006) The social worker and psychotropic medication: toward effective collaboration with mental health clients, families and providers. Thomson, Brooks/Cole, Belmont
Betensky JD, Robinson DG, Gunduz-Bruce H et al (2008) Patterns of stress in schizophrenia. Psychiatry Res 160(1):38–46
Birchwood M, Smith J, Macmillan F et al (1989) Predicting relapse in schizophrenia: the development and implementation of an early signs monitoring system using patients and families as observers. Psychol Med 19:649–656
Birchwood M, Todd P, Jackson C (1998) Early intervention in psychosis. The critical period hypothesis. Br J Psychiatry Suppl 172:53–59
Brent BK, Giuliano AJ, Zimmet SV, Keshavan MS, Seidman LJ (2011) Insight into illness in patients and caregivers during early psychosis: a pilot study. Schizophr Res 127:100–106
Butzlaff RL, Hooley JM (1998) Expressed emotion and psychiatric relapse. Arch Gen Psychiatry 55:547–552
Cassidy E, Hill S, O’Callaghan E (2001) Efficacy of a psychoeducational intervention in improving relatives’ knowledge about schizophrenia and reducing rehospitalisation. Eur Psychiatry 16(8):446–450
Chan SK, Chan KK, Lam MM et al (2012) Clinical and cognitive correlates of insight in first-episode schizophrenia. Schizophr Res 135(1–3):40–45
Chan KW, Chan PM et al (2013) Comorbid substance abuse in early psychosis. In: Chen (ed) Early psychosis intervention: a culturally adaptive clinical guide, 1st edn. Hong Kong University Press, Hong Kong, pp 301–310
Chan SKW, Hui CLM, Wong GHY, Lee EHM, Chang WC, Chen EYH (2014) Medication adherence, knowledge about psychosis and insight among patients with a schizophrenia-spectrum disorder. J Nerv Ment Dis 202(1):25–29
Chen EYH, Tam DKP, Wong JWS, Law C, Chiu CPY (2005) Self-administered instrument to measure the patient’s experience of recovery after first episode psychosis: development and validation of the Psychosis Recovery Inventory. Aust N Z J Psychiatry 39(6):493–499
Chen EY, Hui CL, Lam MM et al (2010) Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial. BMJ (Clinical Research Ed.) 341:c4024
Chien WT, Chan SWC, Thompson DR (2006) Effects of a mutual support group for families of Chinese people with schizophrenia: 18-month follow-up. Br J Psychiatry 189:41–49
Chen EY, Tang JY, Hui CL (2011) Three-year outcome of phase-specific early intervention for first-episode psychosis: a cohort study in Hong Kong. Early Interv Psychiatry 5(4):315–323
Compton M, Quintero L, Esterberg M (2007) Assessing knowledge of schizophrenia: development and psychometric properties of a brief, multiple-choice knowledge test for use across various samples. Psychiatry Res 151(1–2):87–95
First MB (1997) User’s guide for the structured clinical interview for DSM-IV axis I disorders SCID-I: clinician version. Amer Psychiatric Pub Inc, Washington
Gabrenya WK, Hwang KK (1996) Chinese social interaction: harmony and hierarchy on the good earth. In: Bond MH (ed) The handbook of Chinese psychology. Oxford University Press, Hong Kong, pp 309–321
Gleeson JF, Rawlings D, Jackson HJ, McGorry PD (2005) Early warning signs of relapse following a first episode of psychosis. Schizophr Res 80(1):107–111
Hsiao FH, Klimidis S, Minas H, Tan ES (2006) Cultural attribution of mental health suffering in Chinese societies: the views of Chinese patients with mental illness and their caregivers. J Clin Nurs 15(8):998–1006
Hui CLM, Chen EYH, Kan CS, Yip KC, Law CW, Chiu CPY (2006) Anti-psychotics adherence among out-patients with schizophrenia in Hong Kong. Keio J Med 55(1):9–14
Hui CL, Chang WC, Chan SK et al (2013) Early intervention and evaluation for adult-onset psychosis: the JCEP study rationale and design. Early Interv Psychiatry. doi:10.1111/eip.12034
Hui CL, Tang JY, Leung CM et al (2013) A 3-year retrospective cohort study of predictors of relapse in first-episode psychosis in Hong Kong. Aust N Z J Psychiatry 47(8):746–753
Jorm AF, Blewitt KA, Griffiths KM, Kitchener BA, Parslow RA (2005) Mental health first aid responses of the public: results from an Australian national survey. BMC Psychiatry 5(1):9
Jones PB, Barnes TRE, Davies L et al (2006) Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia. Arch Gen Psychiatry 63:1079–1087
Jørgensen P (1998) Early signs of psychotic relapse in schizophrenia. Br J Psychiatry 172:327–330
Kampman O, Laippala P, Vaananen J et al (2002) Indicators of medication compliance in first-episode psychosis. Psychiatry Res 110:39–48
Kay SR, Flszbein A, Opfer LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13(2):261–275
Kazadi NJB, Moosa MYH, Jeenah FY (2008) Factors associated with relapse in schizophrenia. S Afr J Psychiatry 14(2):52–62
Krueger K, Bruce B, Bill F (2005) Medication adherence and persistence: a comprehensive review. Adv Ther 22(4):313–356
Kung WW (2003) The illness, stigma, culture, or immigration? Burdens on Chinese American caregivers of patients with schizophrenia. Fam Soc 84(4):547–557
Lacro JP, Dunn LB, Dolder CR et al (2002) Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 63:892–908
Lam MM, Pearson V, Ng RM, Chiu CP, Law CW, Chen EY (2011) What does recovery from psychosis mean? Perceptions of young first-episode patients. Int J Soc Psychiatry 57(6):580–587
Leucht S, Barnes TR, Kissling W, Engel RR, Correll C, Kane JM (2003) Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Am J Psychiatry 160:1209–1222
Li Z, Arthur D (2005) Family education for people with schizophrenia in Beijing, China: randomized controlled trial. Br J Psychiatry 187:339–345
Lieberman JA, Stroup TS, McEvoy JP et al (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353(12):1209–1223
McWilliams S, Egan P, Jackson D et al (2010) Caregiver psycho-education for first-episode psychosis. Eur Psychiatry 25(1):33–38
Marshall M, Rathbone J (2006) Early intervention for psychosis. Cochrane Database Syst Rev 4:CD004718
Mitchell AJ, Selmes T (2007) Why don’t patients take their medicine? Reasons and solutions in psychiatry. Adv Psych Treat 13:336–346
Ng RMK, Mui J, Cheung HK, Leung SP (2001) Expressed emotion and relapse of schizophrenia in Hong Kong. Hong Kong J Psychiatry 11:4–11
Parashos IA, Xiromeritis K, Zoumbou V, Stamouli S, Theodotou R (1999) The problem of non-compliance in schizophrenia: opinions of patients and their relatives. A pilot study. Int J Psychiatry Clin Pract 4(2):147–150
Perkins DO (2002) Predictors of nonadherence in patients with schizophrenia. J Clin Psychiatry 63:12–16
Pinikahana J (2005) Determinants of medication compliance in schizophrenia. In: Pletson JE (ed) Progress in Schizophrenia research. Nova Science Publishers, Hauppauge, pp 131–148
Rabinovitch M, Béchard-Evans L, Schmitz N, Joober R, Malla A (2009) Early predictors of nonadherence to antipsychotic therapy in first-episode psychosis. Can J Psychiatry 54(1):28–35
Robinson D, Woerner MG, Alvir JM et al (1999) Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 56:241–247
Roe D, Chopra M, Wagner B, Katz G, Rudnick A (2004) The emerging self in conceptualizing and treating mental illness. J Psychosoc Nurs 42:32–40
Sin J, Moone N, Wellman N (2005) Developing services for the carers of young adults with early-onset psychosis–listening to their experiences and needs. J Psychiatr Ment Health Nurs 12(5):589–597
Singh SP, Fisher H (2004) Early intervention services. Psychiatry 3:17–21
Sellwood W, Tarrier N, Quinn J, Barrowclough C (2003) The family and compliance in schizophrenia: the influence of clinical variables, relatives’ knowledge and expressed emotion. Psychol Med 33(1):91–96
Stephenson J (2000) Delay in treating schizophrenia may narrow therapeutic window of opportunity. JAMA 283(16):2091–2092
Tang JY, Wong GH, Hui CL et al (2010) Early intervention for psychosis in Hong Kong—the EASY programme. Early Interv Psychiatry 4:214–219
Tait L, Birchwood M, Trower P (2003) Predicting engagement with services for psychosis: insight, symptoms and recovery style. Br J Psychiatry 182:123–128
Thieda P, Beard S, Ritchter A, Kane J (2003) An economic review of adherence with medication therapy in the treatment of schizophrenia. Psychiatr Serv 54:508–516
Thompson K, Kulkarni J, Sergejew AA (2000) Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 42(3):241–247
Thompson KN, McGorry PD, Harrigan SM (2003) Recovery style and outcome in first-episode psychosis. Schizophr Res 62:31–36
Velligan DI, Lam YWF, Glahn DC et al (2006) Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull 32(4):724–742
Weiss RD (2004) Adherence to pharmacotherapy in patients with alcohol and opioid dependence. Addiction 99(11):1382–1392
Wiersma D, Nienhuis FJ, Slooff CJ, Giel R (1998) Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr Bull 24(1):75–85
Acknowledgments
We are grateful for the support and invaluable advice provided by Professor Peter Jones of the Department of Psychiatry, the University of Cambridge for the modification of the questionnaire of KASI. The study has been approved by the Institutional Review Board of the University of Hong Kong. Informed consent has been obtained from all the participants of this study and patient anonymity has been preserved based on the required standards. This study was not supported by specific research grant.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chan, K.W.S., Wong, M.H.M., Hui, C.L.M. et al. Perceived risk of relapse and role of medication: comparison between patients with psychosis and their caregivers. Soc Psychiatry Psychiatr Epidemiol 50, 307–315 (2015). https://doi.org/10.1007/s00127-014-0930-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00127-014-0930-0